Deshpande, Vrushali <br/><br/>
Oral administration of recombinant Mycobacterium smegmatis expressing a tripeptide construct derived from endogenous and microbial antigens prevents atherosclerosis in ApoE(-/-) mice.  [electronic resource] 

 -  Cardiovascular therapeutics  Oct 2016 
 - 314-24 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1755-5922 
<br/><br/><label>Standard No.: </label>10.1111/1755-5922.12201  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Animals<br/>Antigens--administration & dosage<br/>Aortic Diseases--genetics<br/>Apolipoproteins E--deficiency<br/>Atherosclerosis--genetics<br/>CTLA-4 Antigen--immunology<br/>Disease Models, Animal<br/>Female<br/>Forkhead Transcription Factors--immunology<br/>Genetic Predisposition to Disease<br/>Genetic Vectors<br/>Immune Tolerance<br/>Immunization<br/>Immunotherapy--methods<br/>Inflammation Mediators--immunology<br/>Interleukin-10--immunology<br/>Lipid Metabolism<br/>Macrophages--immunology<br/>Male<br/>Mice, Inbred C57BL<br/>Mice, Knockout<br/>Mycobacterium smegmatis--genetics<br/>Oligopeptides--administration & dosage<br/>Phenotype<br/>T-Lymphocytes, Regulatory--immunology<br/>Time Factors<br/>Transforming Growth Factor beta--immunology<br/>Vaccines, Synthetic--administration & dosage